Tag Directory > Tissue Plasminogen Activator (Tpa)
- Home
- >>
Tags
We have 6 results for Tissue Plasminogen Activator (Tpa).
Why thrombolysis rarely fails in right coronary artery ? 1 Citation Differential response of thrombolysis between left and right coronary system Thrombolysis is the specific treatment for acute myocardial infarction. ( Privileged few , get primary PCI)) Failed thrombolysis occurs in significant number of patients ( 30-40%). Persistent ST elevation 120 minutes after thrombolysis is best indicator of failed thrombolysis. It has been a consistent observation failed thromolysis almost always occur in anterior or LAD myocardial infarction. In a simple study we h, technorati.com
|
1 Citation Seu computador não tem MSN? Tadinho... usa o meebo que tpa tudo certo, com ele você loga ao mesmo tempo no ICQ, MSN, Y! Messenger e gTalk. E o melhor, tudo isso num ótimo sistema AJAX., blogmarks.net
|
Thrombolysis in myocardial infarction 1 Citation Chronology of development of thrombolytic agents First Generation: Streptokinase (1986)? Anisoylated plasminogen streptokinase activator complex (APSAC) (1988)? Second Generation: Alteplase (1994)? - Recombinant tissue plasminogen activator Third Generation: Reteplase (1995)? Lanoteplase (1998)? Tenecteplase (1999)? - TNK tPA Characteristics of an ideal thrombolytic agent 1. Long half-life 2. Single-bolus administration 3. High fibrin specificity/decreased bleeding and intracran, technorati.com
|
Through telemedicine, we have a survivor 1 Citation As this example from a USA Today article, the right technology used in the right way can help save a life. It started with classic symptoms - a women with slurred speech and sagging face - on Thanksgiving Day. Problem: She was 200 miles away from a neurologist. Through telemedicine, the doctor looked at the patient, spoke to the patient, went over a brain scan and diagnosed the stroke. Experiences such as those are why the Mayo Clinic physician and others see telemedicine as one soluti, technorati.com
|
Another study about clot-busting developments 1 Citation Not long ago, researchers from Johns Hopkins University released a study about the use of an aggressive clot-busting treatment for stroke patients. New results from a multicenter study led by Johns Hopkins show that patients who got an experimental clot-busting treatment for a particularly lethal form of stroke were not only dramatically more likely to survive but also continued to shed lingering disabilities six months later. The findings, announced Feb. 19 at the International Stroke Conf, technorati.com
|
Hospitals might miss tPA benefits 1 Citation Patients who need clotbusting tPA can fall through the cracks, as this recent Modern Medicine article illustrates: Two-thirds of US hospitals do not administer tissue plasminogen activator (t-PA) to patients who have a stroke and are covered by Medicare, according to the results of a national study conducted between 2005 and 2007, which were presented at the International Stroke Conference 2009. Furthermore, many of these patients reside in counties that do not have a hospital that delivers, technorati.com
|